PROTXX

PROTXX is a private digital health and medical device company developing wearable neurophysiological assessment tools for neurology, rehabilitation medicine, and sports medicine. Its core offering is the PROTXX Clinic platform, which combines the Phybrata wearable sensor, a mobile application, and cloud-based machine-learning analytics to generate quantitative measures of neurological impairment. The company focuses on rapid, non-invasive assessment and longitudinal monitoring of conditions such as concussion, stroke, multiple sclerosis, and Parkinson's disease. PROTXX positions its technology as a lower-cost, easier-to-use alternative to complex lab-based testing and also supports remote patient monitoring and research use cases. The company appears to commercialize research-use and clinical decision-support tools rather than approved therapeutic drugs.